Bree Eaton, MD

Assistant Professor

Department of Radiation Oncology


(404) 778-3473


Emory Proton Therapy Center



Bree Eaton, MD, is a board certified radiation oncologist in the Department of Radiation Oncology at Emory University School of Medicine in Atlanta, GA. Dr. Eaton practices general radiation oncology and specializes in the treatment of head and neck cancer, adult brain tumors, pediatric cancers and proton therapy. She treats patients at Winship Cancer Institute of Emory University and Emory Proton Therapy Center.

Outside of work, Dr. Eaton enjoys spending time outdoors with her husband and son, as well as running, cooking, listening to live music and traveling.


Dr. Eaton graduated summa cum laude from Denver University with a BS in Cognitive Neuroscience, and completed medical school at the Medical University of South Carolina where she was elected in the Alpha Omega Alpha medical honors society. Dr. Eaton completed her Radiation Oncology Residency at Emory University where she was selected to serve as chief resident during her final year. As Chief Resident at Emory, Dr. Eaton was involved in the coordination of clinical and didactic training for the residency program comprised of 16 residents. Dr. Eaton went on to complete a fellowship in Pediatric Proton Radiotherapy and Clinical Research at Massachusetts General Hospital/Harvard University Medical School in Boston, Massachusetts.


Dr. Eaton has been extensively involved in clinical research evaluating the use of radiotherapy in pediatric and adult malignancies. She serves on the NRG Oncology Patient Centered Outcomes Research Committee and completed an intensive five-day fellowship at the Radiation Therapy Oncology Group Headquarters focusing on radiation oncology research. She has been involved with research protocols, particularly related to evaluating new ways of delivering radiotherapy for adult and pediatric brain tumors and assessing the effects of radiation on quality of life.


Dr. Eaton is the co-author of several articles on clinical outcomes with radiotherapy for adult and pediatric malignancies.

Additional Websites